Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Endocrinology · Hyperprolactinemia

Cabergoline vs Bromocriptine: Which Treats High Prolactin?

At a Glance

For many people with a prolactinoma, cabergoline is preferred because it usually lowers prolactin more effectively, is taken less often, and is better tolerated than bromocriptine. Bromocriptine remains useful when pregnancy planning or individual response affects the choice.

In this answer

5 sections

01

Normalizing Prolactin and Shrinking Tumors

02

A More Convenient Dosing Schedule

03

Better Tolerability and Side Effects

04

Pregnancy Considerations

05

When to Seek Urgent Care

If your endocrinologist prescribed cabergoline instead of bromocriptine, it is because cabergoline is often the first-line choice for a confirmed, symptomatic prolactinoma (a usually noncancerous pituitary tumor) [1]. Both medications are dopamine agonists [2]. They work by stimulating dopamine receptors (specifically D2 receptors) on the pituitary gland, which tells the tumor to stop releasing prolactin [2].

While the choice of medication is highly individualized, clinical guidelines—including the influential 2011 Endocrine Society guidelines—often prefer cabergoline [3]. This is because it is generally more effective, easier to take, and better tolerated by most patients [1][4].

Normalizing Prolactin and Shrinking Tumors

The main goals of medication are to normalize prolactin levels and reduce the tumor’s size [2].

  • Prolactin Normalization: Cabergoline is highly effective at bringing prolactin back into the normal range and resolving symptoms like absent menstrual periods (amenorrhea) and unexpected breast milk production (galactorrhea) [4]. For example, in a review of “giant” prolactinomas (which are very large and difficult to treat), cabergoline normalized prolactin in about 69% of cases, compared to roughly 32% with bromocriptine [5].
  • Tumor Shrinkage: Cabergoline can successfully shrink most prolactinomas [6]. Even for people who do not respond well to bromocriptine, switching to cabergoline can often normalize prolactin and reduce the tumor size [7].

If cabergoline does not work for you, your doctor has other options, such as adjusting the dose, switching to bromocriptine, or, in some cases, considering surgery [8].

A More Convenient Dosing Schedule

Because cabergoline stays in the body longer, it usually only needs to be taken once or twice a week [9][10]. Bromocriptine is metabolized (broken down) much more quickly and must be taken every day, sometimes multiple times a day [11][12]. A once- or twice-weekly pill is far easier to remember, which helps many people stick to their treatment plan over the long term [13].

Better Tolerability and Side Effects

All dopamine agonists can cause side effects like nausea, headaches, and orthostatic hypotension (a sudden drop in blood pressure that causes dizziness when standing up) [14][4]. If you feel dizzy, stand up slowly. Never change or double your dose without speaking to your doctor—side effects can often be managed by starting at a very low dose and increasing it gradually [8].

Overall, analyses of multiple clinical trials show cabergoline has a better overall safety profile than bromocriptine [14]. However, it is not risk-free:

  • Impulse-Control Disorders: These are uncommon but important. Some people develop new urges, such as compulsive gambling, shopping, binge eating, or changes in sexual behavior [15]. A trusted family member might notice this before you do. If this happens, contact your doctor promptly; do not stop the medication on your own.
  • Heart Valve Risks: Taking cabergoline for very long periods at higher doses is associated with a risk of heart valve changes [16]. Depending on your dose and how long you take it, your doctor may order an echocardiogram (an ultrasound of the heart) before you start and periodically during treatment to monitor for this [16]. If you experience shortness of breath, leg swelling, or a new heart murmur, tell your doctor.

Pregnancy Considerations

If you might become pregnant, discuss this with your endocrinologist. Bromocriptine has a much longer history of safety data during pregnancy, which is why it was traditionally preferred for people trying to conceive [17]. However, modern reviews show that cabergoline is also generally safe and does not appear to increase the risk of major birth defects, so it is increasingly favored [18].

Important: If you get a positive pregnancy test, contact your endocrinology and obstetric teams immediately. Do not start, stop, or change your dopamine agonist on your own. Many people with small tumors are advised to stop the medication once pregnancy is confirmed, but people with larger tumors may need to continue treatment to prevent the tumor from growing during pregnancy [19].

When to Seek Urgent Care

While many symptoms of a prolactinoma improve over time, some require immediate emergency medical attention. Seek urgent care if you experience:

  • Sudden, severe headache or vomiting.
  • New or rapidly worsening vision loss, or changes to your peripheral vision (visual field).
  • Sudden confusion or fainting.

Common questions in this guide

Why is cabergoline often preferred over bromocriptine for high prolactin?
Both medicines stimulate dopamine receptors to lower prolactin and can shrink a prolactinoma. Cabergoline is often preferred because it generally normalizes prolactin more effectively, lasts longer, and causes fewer bothersome side effects for many people. The best choice still depends on your symptoms, response, pregnancy plans, and other health factors.
How do the dosing schedules for cabergoline and bromocriptine differ?
Cabergoline usually is taken once or twice a week because it remains in the body longer. Bromocriptine is usually taken every day and sometimes more than once a day. Take the medicine exactly as prescribed and ask your clinician before changing the dose.
What side effects should I watch for while taking these medicines?
Nausea, headache, and dizziness when standing can occur with either medicine. Cabergoline can also rarely be linked with new compulsive behaviors, and prolonged high-dose use can affect heart valves; your clinician may recommend an echocardiogram, or heart ultrasound, depending on your dose and treatment length. Report concerning symptoms promptly and do not stop treatment on your own.
Is cabergoline safe if I am planning pregnancy?
Bromocriptine has the longer history of use in pregnancy, while current reviews indicate cabergoline generally does not increase major birth-defect risk. If you are pregnant or get a positive test, contact your endocrinology and obstetric teams promptly. Do not start, stop, or change either medicine without their advice because tumor size and growth risk affect the plan.
How will my doctor check whether the treatment is working?
Your clinician will follow prolactin blood tests, your symptoms, and repeat MRI scans to see whether the tumor is shrinking. If response is inadequate or side effects are troublesome, the dose may be adjusted, the medicine switched, or surgery considered in some cases.
When do high-prolactin or prolactinoma symptoms need emergency care?
Seek urgent medical attention for a sudden severe headache or vomiting, new or rapidly worsening vision loss or peripheral-vision changes, sudden confusion, or fainting. These symptoms can signal a serious problem and should not wait for a routine appointment.

Related questions

Can a Large Prolactinoma Cause Normal Prolactin? Hook Effect Can Hyperprolactinemia Bone Loss Be Reversed With Treatment? Can Men With High Prolactin Produce Breast Milk? Explained Can High Prolactin Cause Weight Gain? Will Treatment Help? Can Thyroid Treatment Lower Prolactin Without Cabergoline?
Show more
How Is High Prolactin From Psychiatric Drugs Managed? How to Prepare for a Prolactin Blood Test: High Levels How Fast Does Fertility Return After Cabergoline Treatment? How to Cope With Pituitary Tumor Anxiety and Stigma? What Is Macroprolactin and When Does It Need Treatment? What Does the Pituitary Stalk Effect Do to Prolactin? Can Long-Term Cabergoline Damage Your Heart Valves? Why Are Prolactinomas Larger at Diagnosis in Men? Explained Why Is Medication Preferred Over Surgery for Prolactinomas?

Get notified when new evidence is published on acquired hyperprolactinemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.

    Vilar L, Abucham J, Albuquerque JL, et al.

    Archives of endocrinology and metabolism 2018; (62(2)):236-263 doi:10.20945/2359-3997000000032.

    PMID: 29768629
  2. 2

    Treatment of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM).

    Benetti-Pinto CL, Prestes Nácul A, Rosa-E-Silva ACJS, et al.

    Archives of endocrinology and metabolism 2024; (68()):e230504.

    PMID: 38578473
  3. 3

    Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.

    Melmed S, Casanueva FF, Hoffman AR, et al.

    The Journal of clinical endocrinology and metabolism 2011; (96(2)):273-88 doi:10.1210/jc.2010-1692.

    PMID: 21296991
  4. 4

    Cabergoline or bromocriptine for prolactinoma?

    Triantafilo N, Castro-Gutiérrez V, Rada G

    Medwave 2016; (16(Suppl3)):e6545 doi:10.5867/medwave.2016.6545.

    PMID: 27689434
  5. 5

    Cabergoline versus bromocriptine for the treatment of giant prolactinomas: A quantitative and systematic review.

    Huang HY, Lin SJ, Zhao WG, Wu ZB

    Metabolic brain disease 2018; (33(3)):969-976 doi:10.1007/s11011-018-0217-3.

    PMID: 29546691
  6. 6

    Prolactin-secreting adenomas: pathogenesis, diagnosis, and management.

    Fleseriu M, Varlamov EV, Akirov A, et al.

    The lancet. Diabetes & endocrinology 2025; (13(10)):874-890 doi:10.1016/S2213-8587(25)00227-X.

    PMID: 40876473
  7. 7

    Management of Dopamine Agonist-Resistant Prolactinoma.

    Maiter D

    Neuroendocrinology 2019; (109(1)):42-50 doi:10.1159/000495775.

    PMID: 30481756
  8. 8

    How to manage intolerance to dopamine agonist in patients with prolactinoma.

    Stumpf MAM, Pinheiro FMM, Silva GO, et al.

    Pituitary 2023; (26(2)):187-196 doi:10.1007/s11102-023-01313-8.

    PMID: 37027090
  9. 9

    Comparative Study of the Effects of Chamomile (Matricaria Chamomilla L.) and Cabergoline on Idiopathic Hyperprolactinemia: A Pilot Randomized Controlled Trial.

    Kabiri M, Kamalinejad M, Bioos S, et al.

    Iranian journal of pharmaceutical research : IJPR 2019; (18(3)):1612-1621 doi:10.22037/ijpr.2019.1100758.

    PMID: 32641968
  10. 10

    Study of Clinical Profile and Early Response to Dopamine Agonist Therapy in Patients of Hyperprolactinemia: Experience at a Tertiary Care Centre of Nepal.

    Nepal R, Bajracharya MR, Karki BB, et al.

    Indian journal of endocrinology and metabolism 2025; (29(6)):667-673 doi:10.4103/ijem.ijem_252_25.

    PMID: 41497301
  11. 11

    THE EFFECT OF RALOXIFENE ON SERUM PROLACTIN LEVEL IN PATIENTS WITH PROLACTINOMA.

    Choudhary C, Hamrahian AH, Bena JF, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2019; (25(7)):684-688 doi:10.4158/EP-2018-0321.

    PMID: 30865525
  12. 12

    Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas.

    Hacisahinogullari H, Canturk S, Dogansen S, Yarman S

    Journal francais d'ophtalmologie 2022; (45(5)):511-518 doi:10.1016/j.jfo.2022.01.002.

    PMID: 35272874
  13. 13

    The Role of Dopamine Agonists in Pituitary Adenomas.

    Giraldi EA, Ioachimescu AG

    Endocrinology and metabolism clinics of North America 2020; (49(3)):453-474 doi:10.1016/j.ecl.2020.05.006.

    PMID: 32741482
  14. 14

    Efficacy and safety in the treatment of hyperprolactinemia: A systematic review and network meta-analysis.

    Fachi MM, de Deus Bueno L, de Oliveira DC, et al.

    Journal of clinical pharmacy and therapeutics 2021; (46(6)):1549-1556 doi:10.1111/jcpt.13460.

    PMID: 34137053
  15. 15

    Impulse Control Disorders in Patients With Hyperprolactinemia on Dopamine Agonist Therapy-How Concerned Should We Be?

    Daftari G, Tritos NA

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2025; (31(7)):938-945 doi:10.1016/j.eprac.2025.04.018.

    PMID: 40316139
  16. 16

    Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: a joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology.

    Steeds RP, Stiles CE, Sharma V, et al.

    Echo research and practice 2019; (6(1)):G1-G8.

    PMID: 30825409
  17. 17

    Cabergoline Use and Pregnancy Outcomes: A Systematic Review.

    Otis AS, Brochet MS, Tremblay Z, et al.

    Birth defects research 2025; (117(3)):e2464 doi:10.1002/bdr2.2464.

    PMID: 40116053
  18. 18

    Mild hyperprolactinemia in a couple: What impact on fertility?

    Maiter D

    Annales d'endocrinologie 2022; (83(3)):164-167 doi:10.1016/j.ando.2022.04.002.

    PMID: 35525260
  19. 19

    Prolactinoma and pregnancy: From the wish of conception to lactation.

    Maiter D

    Annales d'endocrinologie 2016; (77(2)):128-34.

    PMID: 27130071

This comparison is for informational purposes only and does not constitute medical advice. Your endocrinologist should choose and adjust treatment based on your prolactin level, tumor size, symptoms, pregnancy plans, and overall health.